Asia Pacific Non-Emergency Medical Transportation Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Asia Pacific Non-Emergency Medical Transportation Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others), Facility (Intra-Facility and Inter-Facility), Application (Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others), and End User (Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041644
  • Category : Life Sciences
  • No. of Pages : 204
  • Available Report Formats : pdf-format excel-format
Asia Pacific Non-Emergency Medical Transportation Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Nov 2025   |   Report Code: TIPRE00041644
Buy Now

The Asia Pacific Non-Emergency Medical Transportation Market size is expected to reach US$ 5,445.5 Million by 2031 from US$ 2,770.7 Million in 2024. The market is estimated to record a CAGR of 10.1% from 2025 to 2031.

Executive Summary and Asia Pacific Non-Emergency Medical Transportation Market Analysis:

The Asia Pacific non-emergency medical transportation (NEMT) market, which includes China, Japan, India, South Korea, Australia, and nearby nations, is experiencing remarkable growth and stands as the fastest-expanding market worldwide. This upward trend is largely fueled by the growing incidence of chronic illnesses such as cardiovascular diseases and diabetes, which require frequent medical consultations and treatments.

The region's expanding elderly population and the rising need for cost-effective healthcare solutions have significantly boosted demand for dependable patient transportation services. Furthermore, advancements in healthcare infrastructure and increased medical spending are improving access to NEMT across both metropolitan and rural areas. The flourishing medical tourism sector, particularly in India, Thailand, and Singapore, is also creating new opportunities for organized transport providers. In addition, the adoption of modern technologies-including GPS navigation, real-time monitoring, and automated scheduling systems-is enhancing operational efficiency, safety, and overall service quality throughout the Asia Pacific region.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Asia Pacific Non-Emergency Medical Transportation Market: Strategic Insights

asia-pacific-non-emergency-medical-transportation-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Non-Emergency Medical Transportation Market Segmentation Analysis:

  • By Service Type, the Asia Pacific Non-Emergency Medical Transportation Market is segmented into Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others. Private Pay Patient Transportation held the largest share of the market in 2024.
  • By Facility, the Asia Pacific Non-Emergency Medical Transportation Market is segmented into Intra-Facility and Inter-Facility. Inter-Facility held a larger share of the market in 2024.
  • By Application, the Asia Pacific Non-Emergency Medical Transportation Market is segmented into Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others. Mental Health Related Appointments held the largest share of the market in 2024.
  • By End User, the Asia Pacific Non-Emergency Medical Transportation Market is segmented into Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others. Hospitals and Clinics held the largest share of the market in 2024.

Asia Pacific Non-Emergency Medical Transportation Market Report Scope

Report Attribute Details
Market size in 2024 US$ 2,770.7 Million
Market Size by 2031 US$ 5,445.5 Million
CAGR (2025 - 2031) 10.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Service Type
  • Private Pay Patient Transportation
  • Insurance Backed Patient Transportation
  • Courier Services
  • Others
By Facility
  • Intra-Facility
  • Inter-Facility
By Application
  • Dialysis
  • Routine Doctor Visits
  • Mental Health Related Appointments
  • Rehabilitation
  • Others
By End User
  • Hospitals and Clinics
  • Nursing Homes
  • Homecare Settings
  • MCO and State Agencies
  • Healthcare Payers
  • Others
Regions and Countries Covered Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
Market leaders and key company profiles
  • AMR
  • ABC Non-Emergency Medical Transportation, LLC
  • MTM, Inc.
  • Xpress Transportation
  • CJ Medical Transportation
  • VERIDA
  • Elite Medical Transport
  • Acadian Ambulance Service
  • Crothall Healthcare
  • ModivCare
  • Ride Health
  • Roundtrip
  • Transdev
  • One Call
  • Medical Answering Services, LLC

Asia Pacific Non-Emergency Medical Transportation Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Non-Emergency Medical Transportation Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

asia-pacific-non-emergency-medical-transportation-market-cagr

Asia Pacific Non-Emergency Medical Transportation Market Outlook

NEMT companies and transportation network companies (TNCs) are eager to undertake strategic actions to improve access to care. TNCs, such as Uber or Lyft, are known for their on-demand ride-hailing capabilities and user-friendly mobile apps. These features can effectively address the availability and scheduling issues related to NEMT services. Various TNCs are currently developing new platforms or are engaged in collaborations with NEMT and individual healthcare service providers across the globe. Several state agencies are allowing the use of TNCs to provide NEMT services. For instance:

  • In May 2025, the Odisha government announced a plan to regulate private ambulance services in Bhubaneswar. The initiative aims to improve transparency and efficiency in emergency medical transport by setting up standard regulations. Key features include GPS vehicle tracking systems for real-time management and integration with the Odisha Yatri app, allowing people to find and book ambulances using their smartphones. Moreover, regulated fares will be tied to the Consumer Price Index to prevent overcharging. The reforms focus on coordination between departments and digital integration to ensure fair healthcare access, particularly in rural and underserved areas. This initiative shows the growing recognition of the need for efficient and regulated non-emergency medical transport services in India.

Such strategic initiatives focus on enhancing service efficiency, increasing patient accessibility, reducing operational costs, and ensuring better integration with healthcare services. As the NEMT sector continues to grow, these initiatives will be crucial in expanding services and improving the quality of patient care across the globe.

Asia Pacific Non-Emergency Medical Transportation Market Country Insights

By country, the Asia Pacific Non-Emergency Medical Transportation Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2024.

China plans to invest US$ 1.5 trillion over the next few years to further advance its healthcare technology innovation. In addition to the Healthy China 2030 plan, this expenditure is intended to ensure health equity within China through technological advancements and improvements to the healthcare system. According to a report from the Ministry of Civil Affairs and the China National Committee on Ageing, China has one of the largest aging populations in the world. In 2023, there were more than 297 million people aged 60 and older, accounting for 21.1% of the total population. China's aging population faces an increasing burden from chronic diseases, with age being the primary risk factor contributing to their incidence. According to the study "Unmet Needs for Chronic Diseases in China," published in the BMJ Journal in 2024, noncommunicable diseases (NCDs) represent the most significant health threat in the country, accounting for 91% of all deaths. The primary NCDs in China include cardiovascular diseases (43%), cancers (23%), and diabetes mellitus (2%).

China has a vast healthcare market that is rapidly expanding, driven by an aging population, economic growth, and increased health insurance coverage. Chronically ill patients often cause significant concern for their family members due to their frequent need for life-saving health services. This ongoing care can lead to increased medical expenses, transportation costs, and other related expenses. For low-income families, providing a dedicated car for these patients may not be feasible. In such cases, non-emergency medical transportation can be a valuable resource.

Asia Pacific Non-Emergency Medical Transportation Market Company Profiles

Some of the key players operating in the market include AMR, ABC Non-Emergency Medical Transportation, LLC, MTM, Inc., Xpress Transportation, CJ Medical Transportation, VERIDA, Elite Medical Transport, Acadian Ambulance Service, Crothall Healthcare, ModivCare, Ride Health, Roundtrip, Transdev, One Call, Medical Answering Services, LLC, Abba Medical Transportation, LLC, Able Medical Transportation, Inc., Life Ride, Stellar Transport, and Mobility Transportation Services, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Non-Emergency Medical Transportation Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Feb 2026